Market valuation below target due to low ROE and a PBR below 1x
First written in FY2024. 1 of 2 entries say "Restated". Latest entry: FY2025-H1.
No other company in this theme has enough history to compare yet.
- FY2025-H1RestatedAnnual report
「During the interim consolidated accounting period, there were no new major risks or significant changes to the business risks described in the annual securities report that management recognized as potentially having a material effect on the financial position, operating results, or cash flows of the consolidated companies, among the matters concerning business conditions and financial matters described in this Semiannual Report.」
The Company continues to treat existing risks relating to market valuation and corporate value as involving no material changes. - FY2024First statedAnnual report
「The Company's ROE (return on equity) is currently substantially below its cost of shareholders' equity, which it recognizes as being in the 5% range. As the Company's ROE and EPS (earnings per share) results have failed to meet market expectations, its PBR (price-to-book ratio) has remained substantially below 1x.」
The Company explicitly identified ROE below the cost of shareholders' equity and PBR substantially below 1x as issues relating to corporate value and market valuation.